Analysis of the Occurrence of Predicative Factors of Chronic Fatigue in Female Patients with Cancer of the Reproductive Organs with Respect to Stage of Treatment

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2023 Feb 25

PMID 36834426

Authors

Magdalena Klysiak

Sylwia Wieder-Huszla

Dorota Branecka-Wozniak

Katarzyna Karakiewicz-Krawczyk

Izabela Napieracz-Trzosek

Joanna Owsianowska

Anna Jurczak

Aneta Cymbaluk-Ploska

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to search for mechanisms contributing to cancer-related fatigue in patients with gynecologic cancer. The study involved 51 women with advanced endometrial cancer and ovarian cancer undergoing chemotherapy. Data were gathered at four points in time. After giving consent, each of the women had their blood drawn several times (before surgery and the first, third, and sixth cycle of chemotherapy) to determine serum levels of pro- and anti-inflammatory cytokines. Empirical data were collected using the MFSI-SF and an original questionnaire. Cancer-related fatigue (CRF) was present at every stage of treatment, but the highest mean scores were noted before cytoreductive surgery (8.745 ± 4.599), and before the sixth cycle of chemotherapy (9.667 ± 4.493). Statistically significant relationships were found between IL-1α, IL-1β, IL-2, Il-6, and IL-10 and fatigue at different stages of treatment. Older age and an above-normal BMI were the major prerequisite factors for the occurrence of fatigue in female oncological patients. The analysis of changes in cytokine levels and the severity of fatigue may be used to improve our understanding of cancer-related fatigue, and to take action to alleviate the obtrusive symptoms experienced by female patients with cancer of the reproductive organs.

Citing Articles

Clinicopathological Factors and Interleukin-6 Levels Associated With Low Relative Dose Intensity in Women With Breast Cancer Receiving First-Line Chemotherapy.

Hutajulu S, Astari Y, Ucche M, Paramita D, Witaningrum R, Asdie R World J Oncol. 2024; 15(6):942-949.

PMID: 39697422 PMC: 11650615. DOI: 10.14740/wjon1954.

Connecting the dots: the role of fatigue in female infertility.

Li W, Huang X, Wei Y, Yin T, Diao L Reprod Biol Endocrinol. 2024; 22(1):66.

PMID: 38849828 PMC: 11157719. DOI: 10.1186/s12958-024-01235-5.

References

Cheong Y, Shelton J, Laird S, Richmond M, Kudesia G, Li T . IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2002; 17(1):69-75. DOI: 10.1093/humrep/17.1.69. View

Dobrzycka B, Terlikowski S, Kowalczuk O, Kinalski M . Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Eur Cytokine Netw. 2009; 20(3):131-4. DOI: 10.1684/ecn.2009.0161. View

Lee L, Haskill J, Mukaida N, Matsushima K, Ting J . Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol Cell Biol. 1997; 17(9):5097-105. PMC: 232360. DOI: 10.1128/MCB.17.9.5097. View

Orre I, Murison R, Dahl A, Ueland T, Aukrust P, Fossa S . Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun. 2009; 23(6):868-74. DOI: 10.1016/j.bbi.2009.04.003. View

Fletcher M, Zeng X, Barnes Z, Levis S, Klimas N . Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009; 7:96. PMC: 2779802. DOI: 10.1186/1479-5876-7-96. View

Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J . Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer. 1998; 83(4):788-96. DOI: 10.1002/(sici)1097-0142(19980815)83:4<788::aid-cncr24>3.0.co;2-n. View

Bower J, Ganz P, Irwin M, Kwan L, Breen E, Cole S . Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?. J Clin Oncol. 2011; 29(26):3517-22. PMC: 3179252. DOI: 10.1200/JCO.2011.36.1154. View

Brown D, McMillan D, Milroy R . The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2004; 103(2):377-82. DOI: 10.1002/cncr.20777. View

Astrup G, Rustoen T, Miaskowski C, Paul S, Bjordal K . A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy. Cancer Nurs. 2015; 38(6):436-46. DOI: 10.1097/NCC.0000000000000225. View

10.

Bower J, Ganz P, Aziz N, Fahey J, Cole S . T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst. 2003; 95(15):1165-8. DOI: 10.1093/jnci/djg0019. View

11.

Etzioni A . Chronic fatigue syndrome: still a long way to go. Isr Med Assoc J. 2012; 13(12):761. View

12.

Clendenen T, Lundin E, Zeleniuch-Jacquotte A, Koenig K, Berrino F, Lukanova A . Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011; 20(5):799-810. PMC: 3089656. DOI: 10.1158/1055-9965.EPI-10-1180. View

13.

Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A . Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun. 2012; 26(7):1037-44. PMC: 3434312. DOI: 10.1016/j.bbi.2012.04.003. View

14.

Maccio A, Madeddu C, Massa D, Astara G, Farci D, Melis G . Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients. J Cell Mol Med. 2008; 13(9B):3951-9. PMC: 4516542. DOI: 10.1111/j.1582-4934.2008.00408.x. View

15.

Inagaki M, Isono M, Okuyama T, Sugawara Y, Akechi T, Akizuki N . Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manage. 2007; 35(2):153-61. DOI: 10.1016/j.jpainsymman.2007.03.009. View

16.

Bower J, Ganz P, Aziz N, Fahey J . Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002; 64(4):604-11. DOI: 10.1097/00006842-200207000-00010. View

17.

Maccio A, Madeddu C . Inflammation and ovarian cancer. Cytokine. 2012; 58(2):133-47. DOI: 10.1016/j.cyto.2012.01.015. View

18.

Jones S, Jenkins B . Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018; 18(12):773-789. DOI: 10.1038/s41577-018-0066-7. View

19.

Ding A, Porteu F, Sanchez E, Nathan C . Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science. 1990; 248(4953):370-2. DOI: 10.1126/science.1970196. View

20.

Chopra V, Dinh T, Hannigan E . Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol. 1997; 123(3):167-72. DOI: 10.1007/BF01214669. View